Dr. Stephen Freedman Joins Ingenium as Executive Vice President, Corporate Development

29-Nov-2006

Ingenium Pharmaceuticals AG announced that Stephen Freedman, Ph.D., has joined the company as Executive Vice President, Corporate Development. Dr. Freedman's responsibilities will include the strategic development of Ingenium's growing pipeline of pain and chronic inflammatory disease drug candidates and the expansion of Ingenium's presence in the United States.

Prior to joining the company, Dr. Freedman supported Ingenium in the capacity of an expert in drug discovery and development. Dr. Freedman's pharmaceutical industry experience includes more than 10 years at Elan Pharmaceuticals, his last position being Senior Vice President, Head of Global Research at Elan's San Francisco site. Prior to Elan, Dr. Freedman spent over 12 years at Merck & Co., Inc. He received his Ph.D. in Pharmacology from the University of Southampton, England.

Other news from the department people

More news from our other portals

All FT-IR spectrometer manufacturers at a glance